Capricor Therapeutics Inc (CAPR)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 284.36M
P/E Ratio
0.00
Revenue (TTM)
$ 13.39M
Volume
0
52W High
$ 23.40
52W Low
$ 4.92
Dividend Yield
0.00%
Beta
0.73
Technicals
50-Day MA
7.3116
200-Day MA
11.249
52 Week High
23.4
52 Week Low
4.92
About CAPR
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and.
Employees
160
Headquarters
San Diego, CA
CEO
Dr. Frank Isaac Litvack FACC, M.D.